Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Sequencing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Next-Generation Sequencing
1.2.3 Traditional Sequencing Technologies
1.2.4 Other
1.3 Market by Application
1.3.1 Global Human Microbiome Sequencing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Genome Analysis
1.3.3 Metabolome Analysis
1.3.4 Transcriptome Analysis
1.3.5 Other Omics Analysis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Sequencing Market Perspective (2017-2028)
2.2 Human Microbiome Sequencing Growth Trends by Region
2.2.1 Human Microbiome Sequencing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Human Microbiome Sequencing Historic Market Size by Region (2017-2022)
2.2.3 Human Microbiome Sequencing Forecasted Market Size by Region (2023-2028)
2.3 Human Microbiome Sequencing Market Dynamics
2.3.1 Human Microbiome Sequencing Industry Trends
2.3.2 Human Microbiome Sequencing Market Drivers
2.3.3 Human Microbiome Sequencing Market Challenges
2.3.4 Human Microbiome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Sequencing Players by Revenue
3.1.1 Global Top Human Microbiome Sequencing Players by Revenue (2017-2022)
3.1.2 Global Human Microbiome Sequencing Revenue Market Share by Players (2017-2022)
3.2 Global Human Microbiome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Sequencing Revenue
3.4 Global Human Microbiome Sequencing Market Concentration Ratio
3.4.1 Global Human Microbiome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Sequencing Revenue in 2021
3.5 Human Microbiome Sequencing Key Players Head office and Area Served
3.6 Key Players Human Microbiome Sequencing Product Solution and Service
3.7 Date of Enter into Human Microbiome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Sequencing Breakdown Data by Type
4.1 Global Human Microbiome Sequencing Historic Market Size by Type (2017-2022)
4.2 Global Human Microbiome Sequencing Forecasted Market Size by Type (2023-2028)
5 Human Microbiome Sequencing Breakdown Data by Application
5.1 Global Human Microbiome Sequencing Historic Market Size by Application (2017-2022)
5.2 Global Human Microbiome Sequencing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Human Microbiome Sequencing Market Size (2017-2028)
6.2 North America Human Microbiome Sequencing Market Size by Type
6.2.1 North America Human Microbiome Sequencing Market Size by Type (2017-2022)
6.2.2 North America Human Microbiome Sequencing Market Size by Type (2023-2028)
6.2.3 North America Human Microbiome Sequencing Market Share by Type (2017-2028)
6.3 North America Human Microbiome Sequencing Market Size by Application
6.3.1 North America Human Microbiome Sequencing Market Size by Application (2017-2022)
6.3.2 North America Human Microbiome Sequencing Market Size by Application (2023-2028)
6.3.3 North America Human Microbiome Sequencing Market Share by Application (2017-2028)
6.4 North America Human Microbiome Sequencing Market Size by Country
6.4.1 North America Human Microbiome Sequencing Market Size by Country (2017-2022)
6.4.2 North America Human Microbiome Sequencing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Human Microbiome Sequencing Market Size (2017-2028)
7.2 Europe Human Microbiome Sequencing Market Size by Type
7.2.1 Europe Human Microbiome Sequencing Market Size by Type (2017-2022)
7.2.2 Europe Human Microbiome Sequencing Market Size by Type (2023-2028)
7.2.3 Europe Human Microbiome Sequencing Market Share by Type (2017-2028)
7.3 Europe Human Microbiome Sequencing Market Size by Application
7.3.1 Europe Human Microbiome Sequencing Market Size by Application (2017-2022)
7.3.2 Europe Human Microbiome Sequencing Market Size by Application (2023-2028)
7.3.3 Europe Human Microbiome Sequencing Market Share by Application (2017-2028)
7.4 Europe Human Microbiome Sequencing Market Size by Country
7.4.1 Europe Human Microbiome Sequencing Market Size by Country (2017-2022)
7.4.2 Europe Human Microbiome Sequencing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Sequencing Market Size (2017-2028)
8.2 Asia-Pacific Human Microbiome Sequencing Market Size by Type
8.2.1 Asia-Pacific Human Microbiome Sequencing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Human Microbiome Sequencing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Human Microbiome Sequencing Market Share by Type (2017-2028)
8.3 Asia-Pacific Human Microbiome Sequencing Market Size by Application
8.3.1 Asia-Pacific Human Microbiome Sequencing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Human Microbiome Sequencing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Human Microbiome Sequencing Market Share by Application (2017-2028)
8.4 Asia-Pacific Human Microbiome Sequencing Market Size by Region
8.4.1 Asia-Pacific Human Microbiome Sequencing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Human Microbiome Sequencing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human Microbiome Sequencing Market Size (2017-2028)
9.2 Latin America Human Microbiome Sequencing Market Size by Type
9.2.1 Latin America Human Microbiome Sequencing Market Size by Type (2017-2022)
9.2.2 Latin America Human Microbiome Sequencing Market Size by Type (2023-2028)
9.2.3 Latin America Human Microbiome Sequencing Market Share by Type (2017-2028)
9.3 Latin America Human Microbiome Sequencing Market Size by Application
9.3.1 Latin America Human Microbiome Sequencing Market Size by Application (2017-2022)
9.3.2 Latin America Human Microbiome Sequencing Market Size by Application (2023-2028)
9.3.3 Latin America Human Microbiome Sequencing Market Share by Application (2017-2028)
9.4 Latin America Human Microbiome Sequencing Market Size by Country
9.4.1 Latin America Human Microbiome Sequencing Market Size by Country (2017-2022)
9.4.2 Latin America Human Microbiome Sequencing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Sequencing Market Size (2017-2028)
10.2 Middle East & Africa Human Microbiome Sequencing Market Size by Type
10.2.1 Middle East & Africa Human Microbiome Sequencing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Human Microbiome Sequencing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Human Microbiome Sequencing Market Share by Type (2017-2028)
10.3 Middle East & Africa Human Microbiome Sequencing Market Size by Application
10.3.1 Middle East & Africa Human Microbiome Sequencing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Human Microbiome Sequencing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Human Microbiome Sequencing Market Share by Application (2017-2028)
10.4 Middle East & Africa Human Microbiome Sequencing Market Size by Country
10.4.1 Middle East & Africa Human Microbiome Sequencing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Human Microbiome Sequencing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Baseclear B.V.
11.1.1 Baseclear B.V. Company Details
11.1.2 Baseclear B.V. Business Overview
11.1.3 Baseclear B.V. Human Microbiome Sequencing Introduction
11.1.4 Baseclear B.V. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.1.5 Baseclear B.V. Recent Developments
11.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd
11.2.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Company Details
11.2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Business Overview
11.2.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Introduction
11.2.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue in Human Microbiome Sequencing Business (2017-2022)
11.2.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Developments
11.3 Charles River Laboratories International Inc.
11.3.1 Charles River Laboratories International Inc. Company Details
11.3.2 Charles River Laboratories International Inc. Business Overview
11.3.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Introduction
11.3.4 Charles River Laboratories International Inc. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.3.5 Charles River Laboratories International Inc. Recent Developments
11.4 Clinical Microbiomics A/S
11.4.1 Clinical Microbiomics A/S Company Details
11.4.2 Clinical Microbiomics A/S Business Overview
11.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Introduction
11.4.4 Clinical Microbiomics A/S Revenue in Human Microbiome Sequencing Business (2017-2022)
11.4.5 Clinical Microbiomics A/S Recent Developments
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Details
11.5.2 Eurofins Scientific SE Business Overview
11.5.3 Eurofins Scientific SE Human Microbiome Sequencing Introduction
11.5.4 Eurofins Scientific SE Revenue in Human Microbiome Sequencing Business (2017-2022)
11.5.5 Eurofins Scientific SE Recent Developments
11.6 GENEWIZ, Inc.
11.6.1 GENEWIZ, Inc. Company Details
11.6.2 GENEWIZ, Inc. Business Overview
11.6.3 GENEWIZ, Inc. Human Microbiome Sequencing Introduction
11.6.4 GENEWIZ, Inc. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.6.5 GENEWIZ, Inc. Recent Developments
11.7 Illumina, Inc.
11.7.1 Illumina, Inc. Company Details
11.7.2 Illumina, Inc. Business Overview
11.7.3 Illumina, Inc. Human Microbiome Sequencing Introduction
11.7.4 Illumina, Inc. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.7.5 Illumina, Inc. Recent Developments
11.8 Novogene Corporation
11.8.1 Novogene Corporation Company Details
11.8.2 Novogene Corporation Business Overview
11.8.3 Novogene Corporation Human Microbiome Sequencing Introduction
11.8.4 Novogene Corporation Revenue in Human Microbiome Sequencing Business (2017-2022)
11.8.5 Novogene Corporation Recent Developments
11.9 OraSure Technologies, Inc.
11.9.1 OraSure Technologies, Inc. Company Details
11.9.2 OraSure Technologies, Inc. Business Overview
11.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Introduction
11.9.4 OraSure Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.9.5 OraSure Technologies, Inc. Recent Developments
11.10 Oxford Nanopore Technologies, Inc.
11.10.1 Oxford Nanopore Technologies, Inc. Company Details
11.10.2 Oxford Nanopore Technologies, Inc. Business Overview
11.10.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Introduction
11.10.4 Oxford Nanopore Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.10.5 Oxford Nanopore Technologies, Inc. Recent Developments
11.11 Pacific Biosciences of California, Inc.
11.11.1 Pacific Biosciences of California, Inc. Company Details
11.11.2 Pacific Biosciences of California, Inc. Business Overview
11.11.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Introduction
11.11.4 Pacific Biosciences of California, Inc. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.11.5 Pacific Biosciences of California, Inc. Recent Developments
11.12 QIAGEN N.V.
11.12.1 QIAGEN N.V. Company Details
11.12.2 QIAGEN N.V. Business Overview
11.12.3 QIAGEN N.V. Human Microbiome Sequencing Introduction
11.12.4 QIAGEN N.V. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.12.5 QIAGEN N.V. Recent Developments
11.13 Second Genome, Inc.
11.13.1 Second Genome, Inc. Company Details
11.13.2 Second Genome, Inc. Business Overview
11.13.3 Second Genome, Inc. Human Microbiome Sequencing Introduction
11.13.4 Second Genome, Inc. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.13.5 Second Genome, Inc. Recent Developments
11.14 Thermo Fisher Scientific Inc.
11.14.1 Thermo Fisher Scientific Inc. Company Details
11.14.2 Thermo Fisher Scientific Inc. Business Overview
11.14.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Introduction
11.14.4 Thermo Fisher Scientific Inc. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.14.5 Thermo Fisher Scientific Inc. Recent Developments
11.15 Viome, Inc.
11.15.1 Viome, Inc. Company Details
11.15.2 Viome, Inc. Business Overview
11.15.3 Viome, Inc. Human Microbiome Sequencing Introduction
11.15.4 Viome, Inc. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.15.5 Viome, Inc. Recent Developments
11.16 CosmosID
11.16.1 CosmosID Company Details
11.16.2 CosmosID Business Overview
11.16.3 CosmosID Human Microbiome Sequencing Introduction
11.16.4 CosmosID Revenue in Human Microbiome Sequencing Business (2017-2022)
11.16.5 CosmosID Recent Developments
11.17 Leucine Rich Bio Pvt. Ltd.
11.17.1 Leucine Rich Bio Pvt. Ltd. Company Details
11.17.2 Leucine Rich Bio Pvt. Ltd. Business Overview
11.17.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Introduction
11.17.4 Leucine Rich Bio Pvt. Ltd. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.17.5 Leucine Rich Bio Pvt. Ltd. Recent Developments
11.18 Microba
11.18.1 Microba Company Details
11.18.2 Microba Business Overview
11.18.3 Microba Human Microbiome Sequencing Introduction
11.18.4 Microba Revenue in Human Microbiome Sequencing Business (2017-2022)
11.18.5 Microba Recent Developments
11.19 Microbiome Insights Inc.
11.19.1 Microbiome Insights Inc. Company Details
11.19.2 Microbiome Insights Inc. Business Overview
11.19.3 Microbiome Insights Inc. Human Microbiome Sequencing Introduction
11.19.4 Microbiome Insights Inc. Revenue in Human Microbiome Sequencing Business (2017-2022)
11.19.5 Microbiome Insights Inc. Recent Developments
11.20 Molzym GmbH & Co. KG
11.20.1 Molzym GmbH & Co. KG Company Details
11.20.2 Molzym GmbH & Co. KG Business Overview
11.20.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Introduction
11.20.4 Molzym GmbH & Co. KG Revenue in Human Microbiome Sequencing Business (2017-2022)
11.20.5 Molzym GmbH & Co. KG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer